HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

T0001

recombinant fusion protein of human tumor necrosis factor receptor and Fc fragment (rhTNFR:Fc) based on Etanercept

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
- Peptides: 82426
  - Peptide Fragments: 373
    - Immunoglobulin Fragments: 976
      - Immunoglobulin Fc Fragments: 295
        T0001: 1

Experts

1.	Chen, Aihua: 1 article (01/2017)
2.	Chen, Ben: 1 article (01/2017)
3.	Gao, Bei: 1 article (01/2017)
4.	Gu, Chunying: 1 article (01/2017)
5.	Jin, Li: 1 article (01/2017)
6.	Li, Gang: 1 article (01/2017)
7.	Li, Hua: 1 article (01/2017)
8.	Liang, Chencai: 1 article (01/2017)
9.	Shen, Yijun: 1 article (01/2017)
10.	Su, Yong: 1 article (01/2017)

Related Diseases

1.	Rheumatoid Arthritis 01/01/2017 - "These results suggest that T0001 may not only exert improved efficacy in treating rheumatoid arthritis (RA) because of its high affinity to sTNFα but also has a therapeutic potential in CD and UC due to its increased binding to mTNFα with resultant Fc-associated functions (ADCC, in particular) and improved apoptosis."